Methods of treating female subjects in need of in vitro fertilization

Patent metadata

Field	Value
Publication number	US-9267111-B2
Application number	US-201113006752-A
Country	US
Kind code	B2
Filing date	Jan 14, 2011
Priority date	May 17, 2004
Publication date	Feb 23, 2016
Grant date	Feb 23, 2016

Abstract

Described herein are methods of treating a female subject in need of in vitro fertilization to become pregnant by detecting a loss of non-atretic follicles in the female subject and providing in vitro fertilization to the female subject.

First claim

We claim:

1. A method of providing in vitro fertilization to a female subject in need thereof, said method comprising the steps of:
a) determining the presence or absence of Vasa expression in a sample of peripheral blood obtained from the female subject, wherein the absence of Vasa expression corresponds to a loss of non-atretic follicles in the female subject compared to a female subject having a functional reproductive system; and
b) providing in vitro fertilization to the female subject.

2. The method of claim 1 , wherein the female subject is human.

3. The method of claim 1 , wherein the sample is contacted with an antibody that binds to Vasa, a nucleic acid sequence that binds to Vasa mRNA or a combination thereof.

4. The method of claim 1 , wherein determining the presence or absence of Vasa expression in step a) is carried out using a nucleic acid amplification method selected from the group consisting of rtPCR, ligase chain reaction, self sustained sequence replication, transcriptional amplification, Q-Beta Replicase and rolling circle replication.

5. The method of claim 3 , wherein the antibody is anti-MVH.

6. The method of claim 1 , wherein the female subject in need of in vitro fertilization is selected from a population of female subjects consisting of peri-menopausal subjects, post-menopausal subjects, subjects having gone through surgery, subjects having suffered from disease and subjects having suffered from ovarian damage.

7. The method of claim 6 , wherein ovarian damage comprises damage caused by chemotherapy, radiotherapy or a combination of chemotherapy and radiotherapy.

8. The method of claim 7 , wherein the radiotherapy is selected from the group consisting of ionizing radiation, ultraviolet radiation, X-rays and combinations thereof.

9. The method of claim 6 , wherein the disease is selected from the group of reproductive disorders consisting of premature ovarian failure (POF), cancer, polycystic ovary disease, genetic disorders, immune disorders, metabolic disorders and combinations thereof.

10. The method of claim 9 , wherein the reproductive disorder is POF.

11. A method of treating infertility in a female subject in need thereof, comprising:
a) determining the presence or absence of Vasa expression in a sample of peripheral blood cells obtained from the female subject; and
b) providing in vitro fertilization treatment to the female subject if Vasa expression is absent in the peripheral blood cells.

Assignees

• Tilly Jonathan L
• Johnson Joshua
• Gen Hospital Corp

Inventors

• Tilly Jonathan L
• Johnson Joshua

Classifications

• A61P35/00

  Antineoplastic agents · CPC title

• A61P15/18

  Feminine contraceptives · CPC title

• A61P15/16

  Masculine contraceptives · CPC title

• A61P15/12

  for climacteric disorders · CPC title

• A61P15/08

  for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis · CPC title